Literature DB >> 21417235

In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.

Xingfang Su1, Jennifer Fricke, Daniel G Kavanagh, Darrell J Irvine.   

Abstract

Biodegradable core--shell structured nanoparticles with a poly(β-amino ester) (PBAE) core enveloped by a phospholipid bilayer shell were developed for in vivo mRNA delivery with a view toward delivery of mRNA-based vaccines. The pH-responsive PBAE component was chosen to promote endosome disruption, while the lipid surface layer was selected to minimize toxicity of the polycation core. Messenger RNA was efficiently adsorbed via electrostatic interactions onto the surface of these net positively charged nanoparticles. In vitro, mRNA-loaded particle uptake by dendritic cells led to mRNA delivery into the cytosol with low cytotoxicity, followed by translation of the encoded protein in these difficult-to-transfect cells at a frequency of ~30%. Particles loaded with mRNA administered intranasally (i.n.) in mice led to the expression of the reporter protein luciferase in vivo as soon as 6 h after administration, a time point when naked mRNA given i.n. showed no expression. At later time points, luciferase expression was detected in naked mRNA-treated mice, but this group showed a wide variation in levels of transfection, compared to particle-treated mice. This system may thus be promising for noninvasive delivery of mRNA-based vaccines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21417235      PMCID: PMC3354687          DOI: 10.1021/mp100390w

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  81 in total

1.  In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies.

Authors:  I Hoerr; R Obst; H G Rammensee; G Jung
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

2.  pH-Responsive Polymer Microspheres: Rapid Release of Encapsulated Material within the Range of Intracellular pH Financial support was provided by the NSF (Cooperative Agreement No. ECC9843342 to the MIT Biotechnology Process Engineering Center), the NIH (GM26698), and the Department of the Army (Cooperative Agreement DAMD 17-99-2-9-001 to the Center for Innovative Minimally Invasive Therapy). D.M.L. wishes to thank the NIH for a Postdoctoral Fellowship (NRSA Fellowship No. 1 F32 GM20227-01). Scanning electron microscopy and confocal microscopy images were acquired by William Fowle at the Northeastern University Center for Electron Microscopy. Dr. David Putnam, David Ting, and Tommy Thomas are thanked for helpful discussions.

Authors:  David M. Lynn; Mansoor M. Amiji; Robert Langer
Journal:  Angew Chem Int Ed Engl       Date:  2001-05-04       Impact factor: 15.336

3.  Genetic immunization is a simple method for eliciting an immune response.

Authors:  D C Tang; M DeVit; S A Johnston
Journal:  Nature       Date:  1992-03-12       Impact factor: 49.962

4.  Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.

Authors:  Wilson W K Cheng; Theresa M Allen
Journal:  J Control Release       Date:  2007-11-17       Impact factor: 9.776

5.  High performance mRNA transfection through carbonate apatite-cationic liposome conjugates.

Authors:  Fatema T Zohra; Ezharul H Chowdhury; Toshihiro Akaike
Journal:  Biomaterials       Date:  2009-05-02       Impact factor: 12.479

Review 6.  Cationic lipids, lipoplexes and intracellular delivery of genes.

Authors:  Luc Wasungu; Dick Hoekstra
Journal:  J Control Release       Date:  2006-06-28       Impact factor: 9.776

7.  Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues.

Authors:  M R McDermott; J Bienenstock
Journal:  J Immunol       Date:  1979-05       Impact factor: 5.422

8.  Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive system for tumor-targeted delivery of hydrophobic drugs. 1. In vitro evaluations.

Authors:  Dinesh Shenoy; Steven Little; Robert Langer; Mansoor Amiji
Journal:  Mol Pharm       Date:  2005 Sep-Oct       Impact factor: 4.939

Review 9.  Non-cytotoxic polymer vesicles for rapid and efficient intracellular delivery.

Authors:  Hannah Lomas; Marzia Massignani; Khairuddin A Abdullah; Irene Canton; Caterina Lo Presti; Sheila MacNeil; Jianzhong Du; Adam Blanazs; Jeppe Madsen; Steven P Armes; Andrew L Lewis; Giuseppe Battaglia
Journal:  Faraday Discuss       Date:  2008       Impact factor: 4.008

10.  Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro.

Authors:  Amy C Richards Grayson; Anne M Doody; David Putnam
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.580

View more
  69 in total

1.  Modified poly(lactic-co-glycolic acid) nanoparticles for enhanced cellular uptake and gene editing in the lung.

Authors:  Rachel J Fields; Elias Quijano; Nicole Ali McNeer; Christina Caputo; Raman Bahal; Kavi Anandalingam; Marie E Egan; Peter M Glazer; W Mark Saltzman
Journal:  Adv Healthc Mater       Date:  2014-08-25       Impact factor: 9.933

Review 2.  Stimuli-responsive nanocarriers for drug delivery.

Authors:  Simona Mura; Julien Nicolas; Patrick Couvreur
Journal:  Nat Mater       Date:  2013-11       Impact factor: 43.841

Review 3.  Strategies, design, and chemistry in siRNA delivery systems.

Authors:  Yizhou Dong; Daniel J Siegwart; Daniel G Anderson
Journal:  Adv Drug Deliv Rev       Date:  2019-05-15       Impact factor: 15.470

Review 4.  Nanotechnologies in delivery of mRNA therapeutics using nonviral vector-based delivery systems.

Authors:  S Guan; J Rosenecker
Journal:  Gene Ther       Date:  2017-01-17       Impact factor: 5.250

Review 5.  Biomaterials for nanoparticle vaccine delivery systems.

Authors:  Preety Sahdev; Lukasz J Ochyl; James J Moon
Journal:  Pharm Res       Date:  2014-05-22       Impact factor: 4.200

Review 6.  Non-viral vectors for gene-based therapy.

Authors:  Hao Yin; Rosemary L Kanasty; Ahmed A Eltoukhy; Arturo J Vegas; J Robert Dorkin; Daniel G Anderson
Journal:  Nat Rev Genet       Date:  2014-07-15       Impact factor: 53.242

7.  Ultra-small lipid-polymer hybrid nanoparticles for tumor-penetrating drug delivery.

Authors:  Diana Dehaini; Ronnie H Fang; Brian T Luk; Zhiqing Pang; Che-Ming J Hu; Ashley V Kroll; Chun Lai Yu; Weiwei Gao; Liangfang Zhang
Journal:  Nanoscale       Date:  2016-07-14       Impact factor: 7.790

Review 8.  Nanoscale platforms for messenger RNA delivery.

Authors:  Bin Li; Xinfu Zhang; Yizhou Dong
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2018-05-04

Review 9.  Immunotoxicological impact of engineered nanomaterial exposure: mechanisms of immune cell modulation.

Authors:  Xiaojia Wang; Shaun P Reece; Jared M Brown
Journal:  Toxicol Mech Methods       Date:  2013-01-17       Impact factor: 2.987

10.  Biomaterials for mRNA delivery.

Authors:  Mohammad Ariful Islam; Emma K G Reesor; Yingjie Xu; Harshal R Zope; Bruce R Zetter; Jinjun Shi
Journal:  Biomater Sci       Date:  2015-08-17       Impact factor: 6.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.